Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Trastornos del Movimiento
FILTRAR POR:
Por tema
654 ARTÍCULOS , VIENDO DEL 316 AL 330
The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
Wenning GK, Stankovic I, Vignatelli L, Fanciulli A, Calandra-Buonaura G, Seppi K, Palma JA, Meissner WG, Krismer F, Berg D, Cortelli P, Freeman R, Halliday G, Höglinger G, Lang A, Ling H, Litvan I, Low P, Miki Y, Panicker J, Pellecchia MT, Quinn N, Sakakibara R, Stamelou M, Tolosa E, Tsuji S, Warner T, Poewe W, Kaufmann H.
Mov Disord. 2022 Jun;37(6):1131-1148. doi: 10.1002/mds.29005. Epub 2022 Apr 21.
Probing responses to deep brain stimulation with functional magnetic resonance imaging
Loh A, Gwun D, Chow CT, Boutet A, Tasserie J, Germann J, Santyr B, Elias G, Yamamoto K, Sarica C, Vetkas A, Zemmar A, Madhavan R, Fasano A, Lozano AM.
Brain Stimul. 2022 May-Jun;15(3):683-694. doi: 10.1016/j.brs.2022.03.009. Epub 2022 Apr 18.
SARS-CoV-2, COVID-19 and Parkinson's Disease-Many Issues Need to Be Clarified-A Critical Review
Goerttler T, Kwon EH, Fleischer M, Stettner M, Tönges L, Klebe S.
Brain Sci. 2022 Mar 28;12(4):456. doi: 10.3390/brainsci12040456.
Neuromelanin in Parkinson's Disease: Tyrosine Hydroxylase and Tyrosinase
Nagatsu T, Nakashima A, Watanabe H, Ito S, Wakamatsu K.
Int J Mol Sci. 2022 Apr 10;23(8):4176. doi: 10.3390/ijms23084176.
Zhong Z, He X, Ge J, Zhu J, Yao C, Cai H, Ye XY, Xie T, Bai R.
Eur J Med Chem. 2022 Jul 5;237:114378. doi: 10.1016/j.ejmech.2022.114378. Epub 2022 Apr 18.
Mishra RK, Thrasher AT.
J Clin Neurosci. 2022 Jun;100:184-191. doi: 10.1016/j.jocn.2022.04.029. Epub 2022 Apr 26.
The Chinese Parkinson's Disease Registry (CPDR): Study Design and Baseline Patient Characteristics
Zhou X, Liu Z, Zhou X, Xiang Y, Zhou Z, Zhao Y, Pan H, Xu Q, Chen Y, Sun Q, Wu X, Tan H, Li B, Yuan K, Xie Y, Liao W, Hu S, Zhu J, Wu X, Li J, Wang C, Lei L, Tang J, Liu Y, Wu H, Huang W, Wang T, Xue Z, Wang P, Zhang Z, Xu P, Chen L, Wang Q, Wang X, Cheng O, Shen Y, Liu W, Ye M, You Y, Li J, Yan X, Guo J, Tang B; for Parkinson's Disease & Movement Disorders Multicenter Database and Collaborative Network in China (PD-MDCNC).
Mov Disord. 2022 Jul;37(7):1335-1345. doi: 10.1002/mds.29037. Epub 2022 May 3.
Lang M, Grünewald A, Pramstaller PP, Hicks AA, Pichler I.
Cell Mol Life Sci. 2022 May 5;79(5):283. doi: 10.1007/s00018-022-04304-3.
Miller SJ, Campbell CE, Jimenez-Corea HA, Wu GH, Logan R.
Front Neurosci. 2022 Apr 19;16:824191. doi: 10.3389/fnins.2022.824191. eCollection 2022.
Neuroimaging in Glucocerebrosidase-Associated Parkinsonism: A Systematic Review
Filippi M, Balestrino R, Basaia S, Agosta F.
Mov Disord. 2022 Jul;37(7):1375-1393. doi: 10.1002/mds.29047. Epub 2022 May 6.
A brief history of brain iron accumulation in Parkinson disease and related disorders
Foley PB, Hare DJ, Double KL.
J Neural Transm (Vienna). 2022 Jun;129(5-6):505-520. doi: 10.1007/s00702-022-02505-5. Epub 2022 May 9.
Lipopolysaccharide mouse models for Parkinson's disease research: a critical appraisal
Deng I, Bobrovskaya L.
Neural Regen Res. 2022 Nov;17(11):2413-2417. doi: 10.4103/1673-5374.331866.
How Does Deep Brain Stimulation Change the Course of Parkinson's Disease?
Mahlknecht P, Foltynie T, Limousin P, Poewe W.
Mov Disord. 2022 Aug;37(8):1581-1592. doi: 10.1002/mds.29052. Epub 2022 May 12.
Suzuki K, Funakoshi K, Fujita H, Hirata K.
Clin Neuropharmacol. 2022 May-Jun 01;45(3):61-64. doi: 10.1097/WNF.0000000000000501.
Effects of Nordic walking in people with Parkinson's disease: A systematic review and meta-analysis
Salse-Batán J, Sanchez-Lastra MA, Suarez-Iglesias D, Varela S, Ayán C.
Health Soc Care Community. 2022 Sep;30(5):e1505-e1520. doi: 10.1111/hsc.13842. Epub 2022 May 20.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.